In addition to striving to maximize the efficiency of its research center, GC Pharma continues to generate R&D synergy through active investment in biotechnology startups and extensive partnerships with universities, leading corporations, and research organizations worldwide. In particular, the MOGAM Institute for Biomedical Research and partner biotechnology startups in Korea and abroad with exclusive technologies have allowed GC Pharma to strengthen its position in global biopharmaceutical field.
GC Pharma’s R&D
RED DivisionIdentifies and analyzes candidate materials for innovative new drugsHandles early-stage R&D to introduce new products into the pipeline.
MSAT DivisionHandles later-stage R&D and improves products.
Medicine DivisionConducts clinical trials on products before launching.
Development DivisionUndertakes development projects and handles Regulatory Affairs, Business Development.
Partnership with leading corporations worldwide
Biotechnology startup network
at home and abroad
Collaboration with academia
Collaboration with research organizations in and outside Korea